Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors
Published: 18 December 2020
- Understand current guidelines and utilisation of SGLT2i
- Describe the potential mechanism of benefit of SGLT2i
- Initiate and manage SGLT2i in appropriate patients
Introduction, and No Permission Needed – Cardiology Guidelines + Prescribing Practice
Cardiologists Taking the Lead – How Can We Use SGLT2 Inhibitors in Our Clinical Practice?
University of Manitoba, Canada
Dr Shelley Zieroth is currently at SBH Heart Failure and Transplant Clinics and serves as Head of the Medical Heart Failure Program, WRHA Cardiac Sciences Program, and as Associate Professor of the Section of Cardiology at the University of Manitoba, Canada.